Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rafid Kouz"'
Autor:
Mousami Shah, Michael Russell Mullane, Bety Ciobanu, Barbara Yim, Shylendra B Sreenivasappa, Rafid Kouz
Publikováno v:
Journal of Clinical Oncology. 27:e16164-e16164
e16164 Background: Sunitinib is a tyrosine kinase inhibitor active in renal cell cancer (RCC). There is scanty literature of its efficacy in minority population. Methods: 21 patients (pts) with RCC who received sunitinib between February 2006-Septemb
Autor:
Bety Ciobanu, Thomas E. Lad, Shylendra B Sreenivasappa, Samuel Ofori, Lily Hussein, Mousami Shah, K. Adab, Mohammed A. Kassem, Rafid Kouz
Publikováno v:
Journal of Clinical Oncology. 27:7558-7558
7558 Background: Lung cancer is the leading cause of cancer death. Response and survival of patients (pts) with stage III lung cancer in minority population is not well studied. Methods: 79 pts treated between 2001 and 2006 were studied as a retrospe
Autor:
Bety Ciobanu, Rose Catchatourian, Margaret Clare Telfer, Decebal S. Griza, Paula Kovarik, Rafid Kouz, Sunita Nathan, Samuel Ofori-Ntow, Thomas E. Lad
Publikováno v:
Blood. 110:4444-4444
Background: The phenotypic expression of Hodgkin lymphoma among different ethnic groups is not well described. We conducted a study to look at the characteristics and the clinical response of Hodgkin lymphoma patients of different ethnicities to stan
Autor:
Margaret Clare Telfer, Ahmad Jajeh, Bety Ciobanu, Sunita Nathan, Paula Kovarik, Rafid Kouz, Decebal S. Griza, Samuel Ofori-Ntow, Rose Catchatourian
Publikováno v:
Journal of Clinical Oncology. 25:18510-18510
18510 Background: There is scant literature on the characteristics of Hodgkin’s disease in Hispanics. We studied the characteristics of this disease in Hispanics compared to other ethnic-racial groups in our large multiethnic Hodgkin’s disease ca